Lumos Diagnostics Holdings Share Price and Company Fundamentals
Last traded: Yesterday at 1:08 AM
Lumos Diagnostics Holdings Limited operates as an integrated developer and manufacturer of point-of-care (POC) diagnostic tests. The company develops and manufactures proprietary and in-licensed POC diagnostic tests. Its products include FebriDx, a test that differentiates between bacterial and viral respiratory infections; ViraDx, a combined COVID/Influenza test for acute respiratory infections; and CoviDx, an antigen test for COVID-19. The company also engages in the contract research and development services specialized in the innovation, development, commercialization, and manufacturing of point-of-care diagnostic solutions for clinical and consumer applications. It offers its products through distributors primarily in the North American and European markets. The company was founded in 2004 and is headquartered in Melbourne, Australia.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
0.00%
Beta
-
Market cap
-
Enterprise value
-
Company profile
| Primary activities | Development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. |
|---|---|
| Industry / Sector | Diagnostics & Research / Healthcare |
| Website | https://lumosdiagnostics.com |
| Mailing address | Level 4 96-100 Albert Road South Melbourne Melbourne VIC 3205 Australia |
| Phone / Fax | 61 3 9692 7222 / |
| Share registry | COMPUTERSHARE INVESTOR SERVICES PTY LIMITED |
Dividends
More: Lumos Diagnostics Holdings Dividend history, yield and payout ratio
Dividend yield
0.00%
Dividend amount
$0.00
Payout ratio
Lumos Diagnostics Holdings paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is . The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.
LDX's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Aug 2022, following are the company executives and directors listed on Lumos Diagnostics Holdings.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Samuel Lanyon | Exec. Chairman | 321.33k | |
| Mr. Douglas Ward | Chief Exec. Officer | ||
| Mr. Barrie Lambert | Chief Financial Officer | ||
| Dr. Sacha Dopheide Ph.D. | Chief Technology Officer | ||
| Ms. Jennifer Christiansen | VP of Corp. Marketing & Communications | ||
| Ms. Sarah Glubka | Sr. Director of HR | ||
| Ms. Annie Bell | Sr. Director of Medical Affairs | ||
| Ms. Sue Hibbeln | Sr. Director of Regulatory Affairs | ||
| Mr. Paul Kase | Sr. VP of Commercial Operations | ||
| Ms. Melanie Jaye Leydin B.Bus, C.A., CA | Company Sec. | 48 |
Profitability and management effectiveness
Profit margin
-149.23%
Operating margin
-127.04%
Return on assets
-20.41%
Return on equity
-65.42%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Lumos Diagnostics Holdings is and its enterprise value is .
Companies similar to Lumos Diagnostics Holdings (LDX)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Lumos Diagnostics Holdings (ASX:LDX) Frequently Asked Questions
1. What is Lumos Diagnostics Holdings's Stock Symbol?
Lumos Diagnostics Holdings trades on ASX under the ticker symbol "LDX".
2. What is Lumos Diagnostics Holdings's stock price today?
One share of LDX stock can currently be purchased for approximately $0.062.
3. How can I contact Lumos Diagnostics Holdings?
Lumos Diagnostics Holdings's mailing address is Level 4 96-100 Albert Road South Melbourne Melbourne VIC 3205 Australia. The company can be reached via phone at 61 3 9692 7222.
4. What is Lumos Diagnostics Holdings's official website?
The official website of Lumos Diagnostics Holdings is https://lumosdiagnostics.com.
5. Which share registry manages Lumos Diagnostics Holdings's stock?
Lumos Diagnostics Holdings's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.